Detecting Colonic Cells in Blood of Colorectal Cancer Patients
Author Information
Author(s): A Castells, L Boix, X Bessa, L Gargallo, JM Pique
Primary Institution: Hospital Clinic i Provincial, University of Barcelona
Hypothesis
This study aimed to assess the presence of colonic cells in the peripheral blood of colorectal cancer patients at different evolutionary stages.
Conclusion
The study confirmed that CEA mRNA can be detected in the blood of colorectal cancer patients, indicating the presence of circulating malignant cells.
Supporting Evidence
- CEA mRNA was detected in 39 out of 95 colorectal cancer patients (41.1%).
- CEA mRNA positivity significantly correlated with the presence of distant metastases.
- None of the healthy volunteers had detectable CEA mRNA in their blood.
- Five of the nine patients with inflammatory bowel disease had detectable CEA mRNA.
Takeaway
Doctors can find cancer cells in the blood of patients with colorectal cancer, which might help in understanding how far the cancer has spread.
Methodology
The study used reverse transcriptase polymerase chain reaction (RT-PCR) to detect carcinoembryonic antigen (CEA) mRNA in blood samples from colorectal cancer patients and a control group.
Potential Biases
The presence of circulating tumor cells may be influenced by the collection method, potentially leading to bias.
Limitations
The study had a limited control group and could not definitively rule out false-negative results.
Participant Demographics
The median age of participants was 69 years, with 60 men and 35 women.
Statistical Information
P-Value
0.05
Statistical Significance
p=0.05
Want to read the original?
Access the complete publication on the publisher's website